Generics Industry Gets FTC OK For Shortage Prevention Plan

A generic-drug industry proposal to share sensitive information to help avert pending medication shortages will likely not violate antitrust rules, the Federal Trade Commission said Wednesday....

Already a subscriber? Click here to view full article